In addition, Oh et al. showed that IL-32β and IL-32γ inhibit melanoma and colon cancer tumor growth via inhibition of the activated NF-κB and STAT3 in a transgenic mouse model, while the expression of these isoforms is associated with increased infiltration and migration of breast cancer cells [43,60,61]. Here, NFKB1 is linked to breast carcinoma.